A detailed history of Royal London Asset Management LTD transactions in Pfizer Inc stock. As of the latest transaction made, Royal London Asset Management LTD holds 2,393,288 shares of PFE stock, worth $64 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,393,288
Previous 2,329,601 2.73%
Holding current value
$64 Million
Previous $65.2 Million 6.26%
% of portfolio
0.18%
Previous 0.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $1.76 Million - $2 Million
63,687 Added 2.73%
2,393,288 $69.3 Million
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $476,858 - $558,788
-18,878 Reduced 0.8%
2,329,601 $65.2 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $79,404 - $91,181
-3,067 Reduced 0.13%
2,348,479 $65.2 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $999,106 - $1.3 Million
38,236 Added 1.65%
2,351,546 $67.7 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $3.63 Million - $4.25 Million
113,175 Added 5.14%
2,313,310 $76.7 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $6.7 Million - $7.76 Million
185,592 Added 9.21%
2,200,135 $80.7 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $819,469 - $1.07 Million
20,804 Added 1.04%
2,014,543 $82.2 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $3.18 Million - $4.15 Million
76,235 Added 3.98%
1,993,739 $102 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $2.88 Million - $3.51 Million
-65,790 Reduced 3.32%
1,917,504 $84.1 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $694,739 - $823,743
14,931 Added 0.76%
1,983,294 $104 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $3.48 Million - $4.31 Million
75,957 Added 4.01%
1,968,363 $102 Million
Q4 2021

Oct 18, 2022

SELL
$41.32 - $61.25 $2.89 Million - $4.28 Million
-69,889 Reduced 3.56%
1,892,406 $112 Million
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $2.89 Million - $4.28 Million
-69,889 Reduced 3.56%
1,892,406 $112 Million
Q3 2021

Oct 18, 2022

SELL
$39.25 - $50.42 $2.03 Million - $2.61 Million
-51,677 Reduced 2.57%
1,962,295 $84.4 Million
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $2.03 Million - $2.61 Million
-51,677 Reduced 2.57%
1,962,295 $84.4 Million
Q2 2021

Oct 18, 2022

BUY
$35.91 - $40.68 $1.1 Million - $1.25 Million
30,678 Added 1.55%
2,013,972 $78.9 Million
Q2 2021

Jul 14, 2021

SELL
$35.91 - $40.68 $1.51 Million - $1.71 Million
-42,143 Reduced 2.05%
2,013,972 $78.9 Million
Q1 2021

Oct 17, 2022

BUY
$33.49 - $37.77 $2.44 Million - $2.75 Million
72,821 Added 3.67%
2,056,115 $74.5 Million
Q1 2021

Apr 13, 2021

BUY
$33.49 - $37.77 $861,061 - $971,104
25,711 Added 1.27%
2,056,115 $74.5 Million
Q4 2020

Jan 29, 2021

SELL
$33.47 - $42.56 $2.95 Million - $3.76 Million
-88,238 Reduced 4.16%
2,030,404 $74.7 Million
Q3 2020

Nov 04, 2020

SELL
$31.75 - $37.25 $239,903 - $281,461
-7,556 Reduced 0.36%
2,118,642 $76.6 Million
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $2.01 Million - $2.44 Million
-66,718 Reduced 3.04%
2,126,198 $69.4 Million
Q1 2020

May 01, 2020

SELL
$27.03 - $38.62 $500,946 - $715,744
-18,533 Reduced 0.84%
2,192,916 $71.7 Million
Q4 2019

Feb 05, 2020

BUY
$32.92 - $37.36 $1.28 Million - $1.45 Million
38,765 Added 1.78%
2,211,449 $86.1 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $2.03 Million - $2.63 Million
-62,394 Reduced 2.79%
2,172,684 $78.1 Million
Q2 2019

Jul 31, 2019

SELL
$36.98 - $41.52 $3.16 Million - $3.55 Million
-85,513 Reduced 3.68%
2,235,078 $96.9 Million
Q1 2019

Apr 30, 2019

SELL
$37.5 - $41.2 $6.35 Million - $6.98 Million
-169,449 Reduced 6.81%
2,320,591 $0
Q4 2018

Jan 29, 2019

BUY
$38.47 - $43.86 $6.46 Million - $7.36 Million
167,837 Added 7.23%
2,490,040 $107 Million
Q3 2018

Nov 08, 2018

SELL
$34.47 - $41.81 $4.62 Million - $5.6 Million
-134,012 Reduced 5.46%
2,322,203 $0
Q2 2018

Sep 19, 2018

BUY
$32.98 - $35.16 $81 Million - $86.4 Million
2,456,215 New
2,456,215 $89.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.